Cargando…

CT or MR Enterography to Assess Response During Vedolizumab Therapy for Small Bowel Crohn’s Disease

BACKGROUND: To describe response to therapy of small bowel (SB) Crohn’s disease (CD) at CT or MR enterography (CTE/MRE) in patients on vedolizumab. METHODS: Patients with SB CD who underwent CTE/MRE exams greater than 12 months apart on vedolizumab therapy were included. Length (in cm) and inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwapisz, Lukasz, Bruining, David H, Inoue, Akitoshi, Lee, Yong S, Edwards, Phillip K, Holmes, David R, Carter, Rickey E, Siegelman, Jenifer, Fletcher, Joel G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802241/ https://www.ncbi.nlm.nih.gov/pubmed/36777547 http://dx.doi.org/10.1093/crocol/otac003

Ejemplares similares

Using MR Enterography and CT Enterography for Routine Crohn’s Surveillance: How We Do It Now, and How We Hope to Do it in the Future
por: Kwapisz, Lukasz, et al.
Publicado: (2022)

Small bowel MR enterography: problem solving in Crohn’s disease
por: Griffin, Nyree, et al.
Publicado: (2012)

Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn’s Disease Using Magnetic Resonance Enterography
por: Bouhnik, Yoram, et al.
Publicado: (2022)

MR enterography imaging of Crohn’s disease in pediatric patients
por: Podgórska, Joanna, et al.
Publicado: (2014)

Comparative study between bowel ultrasound and magnetic resonance enterography among Egyptian inflammatory bowel disease patients
por: Kamel, Shimaa, et al.
Publicado: (2020)

Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective study
por: Bruining, David Henry, et al.
Publicado: (2020)

Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease
por: Llano, Ernesto M, et al.
Publicado: (2021)

The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response
por: Moy, Matthew P., et al.
Publicado: (2016)

Vedolizumab in Mild-to-Moderate Crohn’s Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study
por: Dotti, Adriana Zanoni, et al.
Publicado: (2023)

Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study
por: Hajjat, Temara M, et al.
Publicado: (2021)

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020)

Computed Tomography Enterography and Magnetic Resonance Enterography in the Diagnosis of Crohn's Disease
por: Kim, Se Hyung
Publicado: (2015)

Multiphase Computed Tomographic Enterography: Diagnostic Yield and Efficacy in Patients With Suspected Small Bowel Bleeding
por: Deepak, Parakkal, et al.
Publicado: (2019)

The challenge of segmental small bowel motility quantitation using MR enterography
por: Menys, A, et al.
Publicado: (2014)

The Early Experience With Vedolizumab in the United States
por: Kochar, Bharati, et al.
Publicado: (2019)

Diffusion-Weighted MR Enterography to Monitor Bowel Inflammation after Medical Therapy in Crohn's Disease: A Prospective Longitudinal Study
por: Huh, Jimi, et al.
Publicado: (2017)

Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease
por: Kumar, Anand, et al.
Publicado: (2020)

Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab
por: Chiorean, Michael, et al.
Publicado: (2020)

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
por: Patel, Dipen, et al.
Publicado: (2022)

MR Enterography Scores Correlate with Degree of Mucosal Healing in Pediatric Crohn’s Disease: A Pilot Study
por: Gladkikh, Maria, et al.
Publicado: (2023)

Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn’s Disease: A Retrospective Claims Database Analysis
por: Ungaro, Ryan C, et al.
Publicado: (2022)

Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease
por: Dulai, Parambir S, et al.
Publicado: (2022)

Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies
por: Sandborn, William J, et al.
Publicado: (2023)

Capsule Endoscopy Complements Magnetic Resonance Enterography and Endoscopy in Evaluating Small Bowel Crohn’s Disease
por: Prichard, David O, et al.
Publicado: (2019)

Shortened oral contrast preparation for improved small bowel distension at MR enterography
por: Bekendam, M. I. J., et al.
Publicado: (2017)

Assessment of Ileal Crohn’s Disease Activity by Gastrointestinal Ultrasound and MR Enterography: A Pilot Study
por: Statie, Răzvan-Cristian, et al.
Publicado: (2023)

A magnetic resonance enterography index for assessing small bowel Crohn’s disease activity
por: Zuo, Ying, et al.
Publicado: (2023)

Is the Mixed Use of Magnetic Resonance Enterography and Computed Tomography Enterography Adequate for Routine Periodic Follow-Up of Bowel Inflammation in Patients with Crohn's Disease?
por: Ha, Jiyeon, et al.
Publicado: (2022)

Motility index measured by magnetic resonance enterography is associated with sex and mural thickness
por: Månsson, Sven, et al.
Publicado: (2020)

Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn’s Disease: A Comparison with MR Enterography
por: Horjus Talabur Horje, C. S., et al.
Publicado: (2015)

Comparison of Conventional Ultrasound and Contrast Enhanced Magnetic Resonance (MR) Enterography in Evaluation Patients with Crohn’s Disease
por: Imsirovic, Bilal, et al.
Publicado: (2018)

Vedolizumab in the treatment of Crohn’s disease of the pouch
por: Khan, Freeha, et al.
Publicado: (2018)

Pediatric Magnetic Resonance Enterography: Focused on Crohn's Disease
por: Lee, So Mi, et al.
Publicado: (2015)

Magnetic resonance enterography predicts the prognosis of Crohn's disease
por: Lee, Ji Hoon, et al.
Publicado: (2018)

Evaluation of ileal Crohn’s disease response to TNF antagonists: Validation of MR enterography for assessing response. Initial results
por: Gordic, Sonja, et al.
Publicado: (2020)

Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn’s Disease?
por: Foti, Pietro Valerio, et al.
Publicado: (2021)

Comparison of magnetic resonance enterography, capsule endoscopy and gastrointestinal radiography of children with small bowel Crohn’s disease
por: LAI, CAN, et al.
Publicado: (2013)

Magnetic resonance enterography and bowel ultrasonography in Saudi Arabian patients with Crohn's disease: A correlation study
por: Ahmad, Rani, et al.
Publicado: (2021)

Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography, Part II: The Reliable Disclosure of Crohn’s Disease and Non-Inflammatory Small Bowel Disorder Plot through MRI Findings
por: Pierro, Antonio, et al.
Publicado: (2023)

The safety of vedolizumab for ulcerative colitis and Crohn's disease
por: Colombel, Jean-Frédéric, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6oaer6u6ng09vm0khf0gdb6uvd